Activation of peroxisome proliferator-activated receptor γ (PPARgamma) induces GPx3 expression, which reduces human skeletal muscle cells’ extracellular H2O2 levels, improving insulin sensitivity by increasing insulin-stimulated glucose uptake and insulin signaling, suggesting it may be a therapeutic target for diabetes mellitus [12]. This evidence concerns the gene GPX3 and diabetes mellitus.